TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H100. A total of 33 filers reported holding TRACON PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,161,000 | -37.6% | 2,597,680 | -5.2% | 0.13% | -23.7% |
| Q2 2019 | $1,862,000 | -50.4% | 2,738,938 | 0.0% | 0.17% | -50.3% |
| Q1 2019 | $3,752,000 | +117.4% | 2,738,938 | 0.0% | 0.34% | +223.8% |
| Q4 2018 | $1,726,000 | -69.3% | 2,738,938 | 0.0% | 0.10% | -71.2% |
| Q3 2018 | $5,615,000 | -20.6% | 2,738,938 | 0.0% | 0.36% | -23.8% |
| Q2 2018 | $7,073,000 | +105.0% | 2,738,938 | +82.6% | 0.48% | +56.7% |
| Q1 2018 | $3,450,000 | -30.9% | 1,500,000 | +0.7% | 0.30% | -27.6% |
| Q4 2017 | $4,992,000 | +59.3% | 1,490,000 | +49.7% | 0.42% | +28.0% |
| Q3 2017 | $3,134,000 | – | 995,000 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 1,889,652 | $18,462,000 | 1.22% |
| WALL STREET ASSOCIATES | 250,000 | $2,442,000 | 0.47% |
| Eventide Asset Management | 403,912 | $3,946,000 | 0.23% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 485,000 | $4,738,000 | 0.18% |
| J. Goldman & Co LP | 170,000 | $1,661,000 | 0.14% |
| QVT Financial LP | 363,292 | $3,549,000 | 0.12% |
| Kinsight, LLC | 10,053 | $98,000 | 0.07% |
| Welch Group, LLC | 33,769 | $330,000 | 0.06% |
| Visium Asset Management, LP | 436,336 | $4,263,000 | 0.06% |
| Candriam S.C.A. | 135,300 | $1,322,000 | 0.03% |